MedPath

Weight Loss Impact on Male Fertility

Not Applicable
Completed
Conditions
Metabolic Syndrome
Obesity
Sub Fertility, Male
Interventions
Dietary Supplement: Very Low Carb Ketogenic Diet
Registration Number
NCT04186767
Lead Sponsor
University of Sao Paulo
Brief Summary

This is a prospective non-randomized unicentric clinical trial, characterized by the inclusion of obese (BMI\> 35) male with subfertility (sperm count showing low sperm counts and / or motility and / or morphology and / or DNA fragmentation). Patients selected at the endocrinology obesity HC-FMUSP outpatient will be submitted to very low calorie diet (VLCK) for 6 months, being reassessed clinically and laboratorially monthly.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
20
Inclusion Criteria

Obesity in male patients

  • Metabolic Syndrome (NCEP-ATP III)
  • Alteration of some of the seminal parameters evaluated in conventional seminal analysis
Exclusion Criteria
  • Other causes of hypogonadotrophic hypogonadism

    • Hypergonadotrophic hypogonadism
    • Contraindications for performance of ketogenic diet:
    • Type 1 or type 2 diabetes mellitus in insulin use
    • Food drive
    • Alcoholism or drug addiction
    • Severe psychiatric illness
    • Use of coumarin anticoagulants
    • Hepatic insufficiency
    • Severe renal impairment
    • Hematologic diseases
    • Cancer in activity,
    • Cardiovascular or cerebrovascular diseases (arrhythmias, recent myocardial infarction, unstable angina, decompensated heart failure, recent stroke)
    • Gout
    • Renal or biliary lithiasis
    • Major depression or other serious psychiatric illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Weight lossVery Low Carb Ketogenic Diet-
Primary Outcome Measures
NameTimeMethod
Seminal evaluationSix months

DNA fragmentation will be combined to report

Secondary Outcome Measures
NameTimeMethod
Brow tissue studySix months

Thermodynamic evaluation of brown adipose tissue using infrared thermography.

Adipose tissue toxins studySix months

Persistent organic pollutants measure: 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD)

Microbiota evaluationSix months

Evaluate the whole intestinal metagenomics before and after the intervention

Body composition changesSix months

Apply body composition digital analyser pre and post intervention.

Metabolic responseSix months

To evaluate the metabolic parameters lipid and glycemic profiles before and after intervention.

Inflamatory responseSix months

To evaluate cytokines TNFa and IL-6 response before and after intervention.

Epigenetic evaluationSix months

To evaluate the epigenetic methylation profile of spermatozoa before and after the intervention

Hormonal measurementsSix months

To evaluate hormonal parameters total testosterone, LH, FSH, insulin before and after intervention.

Adipose tissue evaluationSix months

To evaluate adipokines: leptin, adiponectin, UCP-1, FGF21, irisin and PGC1a measures before and after intervention.

Trial Locations

Locations (1)

Hospital das Clinicas da Faculdade de Medicina da USP

🇧🇷

São Paulo, Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath